MCAF1 抗体
Quick Overview for MCAF1 抗体 (ABIN328301)
抗原
See all MCAF1 (ATF7IP) 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            特异性
- Recognizes human MCAF1.
- 
                                            纯化方法
- Affinity purified
- 
                                            免疫原
- 
                        Recombinant human MCAF1.
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Approved: WB (1:1000 - 1:2000)
 Usage: Suitable for use in Western Blot. Western Blot: 1:1000-1:2000.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.4, 1 % BSA, 0.05 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 
- 
                                            
- 
    - MCAF1 (ATF7IP) (Activating Transcription Factor 7 Interacting Protein (ATF7IP))
- 
                                            别名
- MCAF / ATF7IP
- 
                                            背景
- 
                        Name/Gene ID: ATF7IP
 Synonyms: ATF7IP, ATF-interacting protein, AM, ATF7-interacting protein, ATF-IP, MCAF1, p621, ATFa-associated modulator, HAM, MCAF
- 
                                            基因ID
- 55729
- 
                                            UniProt
- Q6VMQ6
 抗原
- 
                    
 
                                     
                                     
                                    